* HARBOUR BIOMED RAISES $75 MILLION SERIES B+ VENTURE CAPITAL FINANCING TO ACCELERATE ITS INNOVATIVE PIPELINEShares in major shareholders of South Korea's SK Engineering & Construction fell on Wednesday after a collapse of a dam it was building in Laos. In the randomized studies (Study 013 and Study 017), XCOPRI demonstrated significant reductions in seizure frequency compared to placebo at all doses studied.Long-term safety of XCOPRI has been evaluated in the ongoing open-label extensions of the randomized studies and the open-label safety study.
View real-time stock prices and stock quotes for a full financial overview. Additional clinical trials are investigating XCOPRI in other seizure types.Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8611851-sk-life-science-fda-approval/In Study 013, which included a 6-week titration phase followed by a 6-week maintenance phase, a statistically significant 56% reduction in median seizure frequency was seen with XCOPRI 200 mg/day (n=113) versus a 22% reduction with placebo (n=108). Mark Altmeyer has been named President and CEO of Arvelle. "Given the data generated in clinical trials and the FDA acceptance of the NDA, we believe cenobamate has the potential to be an important antiepileptic drug treatment option for adult patients suffering from partial-onset seizures. All quotes delayed a minimum of 15 minutes.Chairman of the Board, Co-Chief Executive Officer SK Biopharmaceuticals Financials: This is the Financials-site for the company SK Biopharmaceuticals on Markets Insider Please note that due to server maintenance, SK Biopharmaceuticals website will be temporarily unavailable between 12:00 – 16:00 on April 19, 2020 (KST). Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. In Study 017, which included a 6-week titration phase followed by a 12-week maintenance phase, patients randomized to XCOPRI 100 mg/day (n=108), 200 mg/day (n=109) or 400 mg/day (n=111) had statistically significant 36%, 55% and 55% reductions in median seizure frequency, respectively, versus a 24% reduction with placebo (n=106). Safety and efficacy have not been established. SK Biopharmaceuticals Co., Ltd. engages in the research and development of new drugs and antibiotics. Arvelle intends to file a Marketing Authorization Application (MAA) for cenobamate for partial-onset seizures in adult patients based on the data generated from SK Biopharmaceuticals' global clinical trial program.Cenobamate is not approved by the FDA, European Medicines Agency (EMA) or any other regulatory authorities. In addition, SK Holdings is focused on reinforcing its growth foundations through profitable and practical management based on financial stability, while raising its enterprise value by investing in new future growth businesses. The Company engaged in the petroleum businesses, mobile communication services, energy and information technology distribution and construction businesses through subsidiaries including SK Innovation Co., Ltd., SK TELECOM CO.,LTD, SK Networks Company Limited, SK Engineering & Construction Co.,Ltd., SK E&S Co., Ltd. and others. As President and CEO of Otsuka America Pharmaceutical, Inc., Altmeyer oversaw the growth of Abilify® into a multi-billion-dollar product. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. * Says it plans to buy 261.9 million shares of ESR Cayman Limited, a property development firmSouth Korea's chips-to-energy conglomerate SK Group has agreed to buy 6.1% of Vietnam's largest firm, Vingroup JSC <VIC.HM>, for $1 billion as it expands its investments in the Southeast Asian country.South Korea's Asiana Airlines Inc <020560.KS> saw its stock jump as much as 23 percent on Tuesday after local media reported a possible takeover by SK Group, before erasing gains after the conglomerate denied having any interest in the airline business.Defense holding company SK Group is planning an initial public offering on the Tel Aviv Stock Exchange at a company valuation of 2 billion shekels ($565 million), Israeli financial news websites reported on Monday.South Korean conglomerate SK Group is in talks with Malaysian state energy firm Petronas for potential joint ventures in petrochemical and renewable energy projects, the head of SK Group's energy business said on Friday.Sk Biopharmaceutical gains preliminary approval for IPO - Korea ExchangePetroVietnam Oil Corp <OIL.HNO> is in talks to sell a 44.72 percent stake to strategic investors later this year, after its $184 million initial public offering in January, its parent Vietnam Oil and Gas Group, or PetroVietnam, said on Wednesday.Shares in major shareholders of South Korea's SK Engineering & Construction dropped on Wednesday after a collapse of a dam it was building in Laos that is feared to have caused dozens of deaths.Co-President, Co-Chief Executive Officer, DirectorSK Holdings Co., Ltd. is a Korea-based company principally engaged in the petroleum business.